191
Views
4
CrossRef citations to date
0
Altmetric
Research Article

The Stability of Aspirin in a Moisture Containing Direct Compression Tablet Formulation

, &
Pages 729-738 | Published online: 20 Oct 2008
 

Abstract

Studies were conducted on the stability of a direct compression tablet formulation containing aspirin as a model hydrolabile drug. EmdexR (a mixed-sugar diluent containing approximately 8 percent moisture) and stearic acid (a lubricant) made up the remainder of the formulation. Both tablets and uncompressed powder blend were manufactured, packaged in storage containers and placed on stability at different storage temperatures. Stability samples were assayed for aspirin and salicylic acid using a stability indicating analytical method. Analysis of the stability data showed that the rate of aspirin decomposition accelerated with time. Also, the aspirin decomposition rate increased with temperature. The data were fit to the empirical equation y = 100 – ktn, where y is the percent aspirin remaining, t is time, and k and n are constants. The formulation showed good stability, with less than one percent decomposition occuring after 1.75 years of storage at room temperature. This result indicates that although the aspirin formulation contained approximately 8 percent moisture, at room temperature the majority of the moisture present in the formulation is not available to react with the aspirin. The apparent activation energy of the solid-state aspirin decomposition was 46 kcal/mole, which is higher than expected. This result may be due to a temperature dependent release of moisture from the EmdexR. Further studies are needed to verify this explanation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.